Management of hereditary angioedema in the UK: a comparison with international guidelines

Clicks: 30
ID: 327818
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #15 of 46 articles by views in Clinical & Experimental Immunology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hereditary angioedema (HAE) is a rare genetic disorder characterised by recurrent episodes of swelling, which can potentially be life-threatening, resulting in substantial physical, psychological, educational and occupational burden. Treatment of HAE is divided into on-demand treatment for acute attacks and long-term prophylaxis for prevention of attacks, and there are now several effective therapies available. However, in the UK, use of on-demand therapy is intended for attacks defined as clinically significant, and access to long-term prophylaxis is determined primarily by frequency-based criteria. In this policy-focused review, we compare UK access criteria with international guidelines on best practice. We conclude that UK access criteria result in a group of HAE patients with persisting unmet need, and this may have a greater impact in children and young people. In view of this, we recommend greater flexibility in access criteria, allowing clinical judgement, shared decision-making, and broader measures of disease burden to inform treatment eligibility, so we can individualise care and fully meet the needs of these patients.
Reference Key
openalex_W7211964501 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Patrick Yong, Jolanta Bernatoniene, Rachel Annals, Charu Chopra, Tanya Coulter, Sarah Denman, Anthony Dorr, Tariq El-Shanawany, Alexandros Grammatikos, Padmalal Gurugama, Rashmi Jain, Sorena Kiani‐Alikhan, Lucy Leeman, Lorena Lorenzo, Ania Manson, Sadia Noorani, Smita Patel, Arthur Price, Ravi Sargur, Cathal Steele, Catherine Stroud, Cassim Akhoon, Ariharan Anantharachagan, Emily Carne, Samuel Chee, Joanne Miller, Stephen Owens, Christine Symons, K C Tan, Michael Tarzi, Scott Hackett, Angela Metcalfe, Sinisa Savic, Tomaz Garcez
Are you one of these authors? Claim your profile
Journal Clinical & Experimental Immunology
Year 2026
DOI
10.1093/cei/uxag056
URL
https://doi.org/10.1093/cei/uxag056
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.